Sam, J., Colombetti, S., Fauti, T., Roller, A., Biehl, M., Fahrni, L., . . . Bacac, M. (2020). Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity. Front Oncol.
Style de citation ChicagoSam, Johannes, et al. "Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity." Front Oncol 2020.
Style de citation MLASam, Johannes, et al. "Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity." Front Oncol 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.